Somatic interpretation is complex and time-critical — tumour boards need clear, defensible molecular answers to guide treatment.
Somatic variant interpretation with TMB, MSI and HRD
Therapy matching against curated evidence
Structured reports for the tumour board
Every call is evidence-linked and auditable.
A qualified reviewer signs off every result.
FHIR reports drop into your existing systems.
Outcome — Confident, timely therapy decisions.
Anchor sites get early capability and a real say in the roadmap.